{"id":"https://openalex.org/W3045337736","doi":"https://doi.org/10.1136/bmjopen-2020-037746","title":"Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer","display_name":"Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer","publication_year":2020,"publication_date":"2020-07-01","ids":{"openalex":"https://openalex.org/W3045337736","doi":"https://doi.org/10.1136/bmjopen-2020-037746","mag":"3045337736","pmid":"https://pubmed.ncbi.nlm.nih.gov/32699133","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7375432"},"language":"en","primary_location":{"id":"doi:10.1136/bmjopen-2020-037746","doi":"https://doi.org/10.1136/bmjopen-2020-037746","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2020-037746","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/10/7/e037746.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmjopen.bmj.com/content/bmjopen/10/7/e037746.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010442577","display_name":"Yuichi Ozawa","orcid":"https://orcid.org/0000-0003-3798-3488","observed_orcids":["https://orcid.org/0000-0003-3798-3488"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yuichi Ozawa","raw_affiliation_strings":["Internal Medicine III, Wakayama Medical University, Wakayama, Japan"],"raw_orcid":"https://orcid.org/0000-0003-3798-3488","affiliations":[{"raw_affiliation_string":"Internal Medicine III, Wakayama Medical University, Wakayama, Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039756899","display_name":"Takeya Sugimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takeya Sugimoto","raw_affiliation_strings":["Internal Medicine III, Wakayama Medical University, Wakayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine III, Wakayama Medical University, Wakayama, Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060791154","display_name":"Yuichiro Azuma","orcid":"https://orcid.org/0000-0001-9884-7215","observed_orcids":["https://orcid.org/0000-0001-9884-7215"]},"institutions":[{"id":"https://openalex.org/I4405283244","display_name":"National Hospital Organization Wakayama Hospital","ror":"https://ror.org/01a6fhn03","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4405283244"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuichiro Azuma","raw_affiliation_strings":["Department of Respiratory Medicine, National Hospital Organization Wakayama Hospital, Mihama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, National Hospital Organization Wakayama Hospital, Mihama, Japan","institution_ids":["https://openalex.org/I4405283244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041228394","display_name":"Yuhei Harutani","orcid":"https://orcid.org/0009-0008-6757-3491","observed_orcids":["https://orcid.org/0009-0008-6757-3491"]},"institutions":[{"id":"https://openalex.org/I4210137409","display_name":"National Hospital Organization","ror":"https://ror.org/03ntccx93","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210137409"]},{"id":"https://openalex.org/I4210153364","display_name":"Minami Wakayama Medical Center","ror":"https://ror.org/04fz99q08","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4210153364"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuhei Harutani","raw_affiliation_strings":["Department of Respiratory Medicine, National Hospital Organization Minami Wakayama Medical Center, Tanabe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, National Hospital Organization Minami Wakayama Medical Center, Tanabe, Japan","institution_ids":["https://openalex.org/I4210137409","https://openalex.org/I4210153364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103274026","display_name":"Takanori Yoshikawa","orcid":"https://orcid.org/0000-0003-4324-4366","observed_orcids":["https://orcid.org/0000-0003-4324-4366"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takanori Yoshikawa","raw_affiliation_strings":["Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032337115","display_name":"Nobuyuki Yamamoto","orcid":"https://orcid.org/0000-0002-7342-0853","observed_orcids":["https://orcid.org/0000-0002-7342-0853"]},"institutions":[{"id":"https://openalex.org/I190805021","display_name":"Wakayama Medical University","ror":"https://ror.org/005qv5373","country_code":"JP","type":"education","lineage":["https://openalex.org/I190805021"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuyuki Yamamoto","raw_affiliation_strings":["Internal Medicine III, Wakayama Medical University, Wakayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine III, Wakayama Medical University, Wakayama, Japan","institution_ids":["https://openalex.org/I190805021"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034282329","display_name":"Kuninobu Kanai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114798","display_name":"Naga Municipal Hospital","ror":"https://ror.org/01e0nt744","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210114798"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kuninobu Kanai","raw_affiliation_strings":["Department of Respiratory Medicine, Naga Municipal Hospital, Kinokawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respiratory Medicine, Naga Municipal Hospital, Kinokawa, Japan","institution_ids":["https://openalex.org/I4210114798"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5010442577"],"corresponding_institution_ids":["https://openalex.org/I190805021"],"apc_list":{"value":1500,"currency":"GBP","value_usd":1839},"apc_paid":{"value":1500,"currency":"GBP","value_usd":1839},"fwci":0.1159,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.44900403,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"10","issue":"7","first_page":"e037746","last_page":"e037746"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5313000082969666,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5313000082969666,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.43140000104904175,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.021199999377131462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":1.0},{"id":"https://openalex.org/keywords/non-squamous-non-small-cell-lung-cancer","display_name":"non-squamous non-small cell lung cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.9610000252723694},{"id":"https://openalex.org/keywords/triplet-chemotherapy","display_name":"triplet chemotherapy","score":0.4819999933242798},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7929999828338623},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8560000061988831},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.8109999895095825},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.8550000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9434585571289062},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.7375284433364868},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.7355402112007141},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6923178434371948},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6187572479248047},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6088827252388},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5655640363693237},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.5436915159225464},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5408364534378052},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4852616488933563},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4792759120464325},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36767905950546265},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.337182879447937},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3164154887199402},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.17795270681381226},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1136/bmjopen-2020-037746","doi":"https://doi.org/10.1136/bmjopen-2020-037746","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2020-037746","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/10/7/e037746.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},{"id":"pmid:32699133","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32699133","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ open","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:pubmedcentral.nih.gov:7375432","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7375432/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"Text"},{"id":"pmh:oai:open-archive.highwire.org:bmjopen:10/7/e037746","doi":null,"is_oa":false,"landing_page_url":"http://bmjopen.bmj.com/cgi/content/short/10/7/e037746","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:doaj.org/article:9c2038878ed14ed7b537c26e00ac1389","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9c2038878ed14ed7b537c26e00ac1389","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMJ Open, Vol 10, Iss 7 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/bmjopen-2020-037746","doi":"https://doi.org/10.1136/bmjopen-2020-037746","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bmjopen-2020-037746","pdf_url":"https://bmjopen.bmj.com/content/bmjopen/10/7/e037746.full.pdf","source":{"id":"https://openalex.org/S79054089","display_name":"BMJ Open","issn_l":"2044-6055","issn":["2044-6055"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMJ Open","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320317195","display_name":"Nichi-Iko Pharmaceutical","ror":"https://ror.org/02rnfc528"},{"id":"https://openalex.org/F4320333376","display_name":"MSD K.K.","ror":"https://ror.org/01kaqxm37"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3045337736.pdf","grobid_xml":"https://content.openalex.org/works/W3045337736.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W1966056387","https://openalex.org/W2121095198","https://openalex.org/W2137009016","https://openalex.org/W2796582438","https://openalex.org/W2947154863","https://openalex.org/W2962053530"],"related_works":["https://openalex.org/W2805443924","https://openalex.org/W2891806577","https://openalex.org/W3012268313","https://openalex.org/W2510052715","https://openalex.org/W2890731087","https://openalex.org/W2121095198","https://openalex.org/W2040992530","https://openalex.org/W3012136773","https://openalex.org/W2345450118","https://openalex.org/W2386928208"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Triplet":[1],"regimen":[2,41,80],"of":[3,55,184],"carboplatin":[4],"or":[5,66],"cisplatin":[6],"with":[7,17],"pemetrexed":[8],"and":[9,100,158],"pembrolizumab":[10],"is":[11],"a":[12],"standard":[13],"treatment":[14],"for":[15,28,69,150],"patients":[16,29,36],"advanced,":[18],"chemo-na\u00efve,":[19],"non-squamous":[20],"non-small":[21],"cell":[22],"lung":[23],"cancer.":[24],"However,":[25],"subgroup":[26],"analysis":[27],"aged":[30],"\u226575":[31],"years":[32],"indicated":[33],"that":[34],"elderly":[35,60,177],"who":[37],"received":[38],"the":[39,59,78,86,116,138,170],"triplet":[40,79,171],"may":[42],"have":[43,131],"had":[44,51],"shorter":[45],"survival":[46],"times":[47],"than":[48],"if":[49],"they":[50],"chemotherapy":[52],"alone":[53],"(HR":[54],"2.09).":[56],"Treatments":[57],"in":[58,85,143,152],"are":[61,94,173],"not":[62],"always":[63],"as":[64,68],"effective":[65],"safe":[67],"non-elderly":[70],"patients,":[71],"so":[72],"there":[73],"remains":[74],"concern":[75],"over":[76],"whether":[77,169],"can":[81],"be":[82,148],"widely":[83],"used":[84],"elderly.":[87],"METHODS":[88],"AND":[89,109],"ANALYSIS:":[90],"V.1.1.":[91],"Secondary":[92],"endpoints":[93],"progression-free":[95],"survival,":[96],"disease":[97],"control":[98],"rate":[99],"safety.":[101],"This":[102,111,162],"trial":[103],"will":[104,140,147,164],"enrol":[105],"22":[106],"patients.":[107,178],"ETHICS":[108],"DISSEMINATION:":[110],"study":[112,139,163],"was":[113],"approved":[114],"by":[115],"Wakayama":[117],"Medical":[118],"University":[119],"Central":[120],"Review":[121],"Board":[122],"on":[123,168],"2":[124],"December":[125],"2019":[126],"(approval":[127],"number:":[128],"W-32).":[129],"Patients":[130],"been":[132],"enrolled":[133],"since":[134],"February":[135],"2020.":[136],"As":[137],"complete":[141],"accrual":[142],"January":[144],"2022,":[145],"results":[146],"submitted":[149],"publication":[151],"peer-reviewed":[153],"medical":[154],"journals":[155],"within":[156],"2023":[157],"international":[159],"scientific":[160],"meetings.":[161],"provide":[165],"significant":[166],"information":[167],"regimens":[172],"clinically":[174],"beneficial":[175],"to":[176],"TRIAL":[179],"REGISTRATION":[180],"NUMBER:":[181],"Japan":[182],"Registry":[183],"Clinical":[185],"Trials":[186],"(jRCTs051190095).":[187]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2020-07-29T00:00:00"}